138 related articles for article (PubMed ID: 20200441)
41. Detection assay for HPV16 and HPV18 by loop‑mediated isothermal amplification with lateral flow dipstick tests.
Kumvongpin R; Jearanaikoon P; Wilailuckana C; Sae-Ung N; Prasongdee P; Daduang S; Wongsena M; Boonsiri P; Kiatpathomchai W; Swangvaree SS; Sandee A; Daduang J
Mol Med Rep; 2017 May; 15(5):3203-3209. PubMed ID: 28339040
[TBL] [Abstract][Full Text] [Related]
42. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
43. A new multiparameter assay to assess HPV 16/18, viral load and physical status together with gain of telomerase genes in HPV-related cancers.
Theelen W; Reijans M; Simons G; Ramaekers FC; Speel EJ; Hopman AH
Int J Cancer; 2010 Feb; 126(4):959-75. PubMed ID: 19711394
[TBL] [Abstract][Full Text] [Related]
44. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy.
Carcopino X; Henry M; Benmoura D; Fallabregues AS; Richet H; Boubli L; Tamalet C
J Med Virol; 2006 Aug; 78(8):1131-40. PubMed ID: 16789021
[TBL] [Abstract][Full Text] [Related]
45. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
46. Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer.
Jaberipour M; Samsami A; Sahraiian F; Kazerooni T; Hashemi M; Ghaderi A; Habibagahi M
Asian Pac J Cancer Prev; 2011; 12(1):163-7. PubMed ID: 21517251
[TBL] [Abstract][Full Text] [Related]
47. Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma.
Arron ST; Ruby JG; Dybbro E; Ganem D; Derisi JL
J Invest Dermatol; 2011 Aug; 131(8):1745-53. PubMed ID: 21490616
[TBL] [Abstract][Full Text] [Related]
48. Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
Montealegre JR; Peckham-Gregory EC; Marquez-Do D; Dillon L; Guillaud M; Adler-Storthz K; Follen M; Scheurer ME
Gynecol Oncol; 2018 Feb; 148(2):357-362. PubMed ID: 29276057
[TBL] [Abstract][Full Text] [Related]
49. The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16.
Wanram S; Limpaiboon T; Leelayuwat C; Yuenyao P; Guiney DG; Lulitanond V; Jearanaikoon P
Am J Obstet Gynecol; 2009 Jul; 201(1):79.e1-7. PubMed ID: 19446285
[TBL] [Abstract][Full Text] [Related]
50. Cervicovaginal loads of
Belleti R; Marcolino LD; Novak J; Ferreira CST; do Nascimento Bolpetti A; da Silva Pinto GV; de Oliveira AP; da Silva MG; Marconi C
J Med Microbiol; 2022 May; 71(5):. PubMed ID: 35580018
[No Abstract] [Full Text] [Related]
51. Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer.
Jeannot E; Latouche A; Bonneau C; Calméjane MA; Beaufort C; Ruigrok-Ritstier K; Bataillon G; Larbi Chérif L; Dupain C; Lecerf C; Popovic M; de la Rochefordière A; Lecuru F; Fourchotte V; Jordanova ES; von der Leyen H; Tran-Perennou C; Legrier ME; Dureau S; Raizonville L; Bello Roufai D; Le Tourneau C; Bièche I; Rouzier R; Berns EMJJ; Kamal M; Scholl S
Clin Cancer Res; 2021 Nov; 27(21):5869-5877. PubMed ID: 34210686
[TBL] [Abstract][Full Text] [Related]
52. The association between viral load and concurrent human papillomavirus infection at the genital and anal sites of young women and the impact of vaccination.
van Eer K; Laâbi I; van Benthem BHB; Steenbergen RDM; King AJ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Tumour Virus Res; 2022 Jun; 13():200233. PubMed ID: 34958987
[TBL] [Abstract][Full Text] [Related]
53. Circulating cell-free HPV DNA is a strong marker for disease severity in cervical cancer.
Bønløkke S; Steiniche T; Sorensen BS; Nyvang GB; Lindegaard JC; Blaakær J; Bertelsen J; Fuglsang K; Strube ML; Lenz S; Stougaard M
Mol Oncol; 2024 May; 18(5):1231-1244. PubMed ID: 37853962
[TBL] [Abstract][Full Text] [Related]
54. High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study.
Turner DO; Williams-Cocks SJ; Bullen R; Catmull J; Falk J; Martin D; Mauer J; Barber AE; Wang RC; Gerstenberger SL; Kingsley K
BMC Oral Health; 2011 Oct; 11():28. PubMed ID: 21985030
[TBL] [Abstract][Full Text] [Related]
55. Human papillomavirus type 16 and 18 in primary lung cancers--a meta-analysis.
Srinivasan M; Taioli E; Ragin CC
Carcinogenesis; 2009 Oct; 30(10):1722-8. PubMed ID: 19620233
[TBL] [Abstract][Full Text] [Related]
56. Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
Xiao H; Chen W; Lin M; Jiang S; Cui X; Zhao S
Anal Methods; 2024 Mar; 16(13):1862-1869. PubMed ID: 38463013
[TBL] [Abstract][Full Text] [Related]
57. Determinants of baseline seroreactivity to human papillomavirus type 16 in the Ludwig-McGill cohort study.
de Araujo-Souza PS; Ramanakumar AV; Candeias JM; Thomann P; Trevisan A; Franco EL; Villa LL;
BMC Infect Dis; 2014 Nov; 14():578. PubMed ID: 25730386
[TBL] [Abstract][Full Text] [Related]
58. Human papillomavirus 16 infection in adenocarcinoma of the cervix.
Chew GK; Cruickshank ME; Rooney PH; Miller ID; Parkin DE; Murray GI
Br J Cancer; 2005 Nov; 93(11):1301-4. PubMed ID: 16265348
[TBL] [Abstract][Full Text] [Related]
59. Detection of HPV16 viral load in L2 gene as a related predictor of cervical cancer among women in Dhi-Qar province by qRT-PCR.
Jalil AT; Khan MUF; Muhammed HA; Kawen AA; Saeed BQ; Karevskiy A
Mol Biol Rep; 2022 Dec; 49(12):11847-11853. PubMed ID: 36214947
[TBL] [Abstract][Full Text] [Related]
60. Association of two genomic variants with HPV type-specific risk of cervical cancer.
Seifert F; Eisenblätter R; Beckmann J; Schürmann P; Hanel P; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Fasching P; Luyten A; Häfner N; Dürst M; Runnebaum IB; Hillemanns P; Dörk T; Ramachandran D
Tumour Virus Res; 2023 Dec; 16():200269. PubMed ID: 37499979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
